DLD Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

DLD Asset Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,000	Closed	-$3.4M	–	209
2022 Q3	$3.4M	Buy	+50,000	New	+$2.76M	0.26%	71

Other funds holding GBT

Blue Trust Inc Alpharetta, Georgia $9.51B AUM 13.02% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

DLD Asset Management's GBT Position: Q4 2022 in Review

DLD Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 50,000 shares — an estimated $3.4M sold.

DLD Asset Management first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $3.4M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

DLD Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
DLD Asset Management sold 50,000 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $3.4M.
DLD Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
DLD Asset Management's Global Blood Therapeutics, Inc. position peaked at $3.4M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on DLD Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.